172 related articles for article (PubMed ID: 15075536)
1. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients.
Gayà A; Esteve A; Casabona J; McCarthy JJ; Martorell J; Schulz TF; Whitby D;
AIDS; 2004 Jan; 18(2):199-204. PubMed ID: 15075536
[TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
3. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.
Dorak MT; Yee LJ; Tang J; Shao W; Lobashevsky ES; Jacobson LP; Kaslow RA
J Med Virol; 2005 Jul; 76(3):302-10. PubMed ID: 15902698
[TBL] [Abstract][Full Text] [Related]
4. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma.
Katano H; Sata T; Suda T; Nakamura T; Tachikawa N; Nishizumi H; Sakurada S; Hayashi Y; Koike M; Iwamoto A; Kurata T; Mori S
J Med Virol; 1999 Nov; 59(3):346-55. PubMed ID: 10502268
[TBL] [Abstract][Full Text] [Related]
5. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
6. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.
André S; Schatz O; Bogner JR; Zeichhardt H; Stöffler-Meilicke M; Jahn HU; Ullrich R; Sonntag AK; Kehm R; Haas J
J Mol Med (Berl); 1997 Feb; 75(2):145-52. PubMed ID: 9083932
[TBL] [Abstract][Full Text] [Related]
7. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
8. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America.
Fouchard N; Lacoste V; Couppie P; Develoux M; Mauclere P; Michel P; Herve V; Pradinaud R; Bestetti G; Huerre M; Tekaia F; de Thé G; Gessain A
Int J Cancer; 2000 Jan; 85(2):166-70. PubMed ID: 10629072
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Cannon MJ; Dollard SC; Black JB; Edlin BR; Hannah C; Hogan SE; Patel MM; Jaffe HW; Offermann MK; Spira TJ; Pellett PE; Gunthel CJ
AIDS; 2003 Jan; 17(2):215-22. PubMed ID: 12545082
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
11. HHV-8 infection in patients with AIDS-related Kaposi's sarcoma in Brazil.
Keller R; Zago A; Viana MC; Bourboulia D; Desgranges C; Casseb J; Moura WV; Dietze R; Collandre H
Braz J Med Biol Res; 2001 Jul; 34(7):879-86. PubMed ID: 11449306
[TBL] [Abstract][Full Text] [Related]
12. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
[TBL] [Abstract][Full Text] [Related]
13. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.
Martró E; Esteve A; Schulz TF; Sheldon J; Gambús G; Muñoz R; Whitby D; Casabona J;
Int J Cancer; 2007 Mar; 120(5):1129-35. PubMed ID: 17154170
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
17. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of BC-3 and BCP-1 cell lines in immunofluorescence assay to detect HHV-8 antibodies in Kaposi's sarcoma, multiple myeloma and other groups.
Couty JP; Ranger-Rogez S; Venot C; Jaccard A; Rogez JP; Weinbreck P; Bordessoule D; Denis F
J Clin Virol; 1999 May; 12(3):221-31. PubMed ID: 10382819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
